Total Intravenous Versus Inhalational Anesthesia in Patients Undergoing Hip Fracture Surgery

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

About this trial

This prospective observational study aims to compare total intravenous anesthesia (TIVA) with sevoflurane-based inhalational anesthesia in patients aged 65 years and older undergoing hip fracture surgery under general anesthesia. The study will evaluate postoperative quality of recovery using the Quality of Recovery-40 (QoR-40) questionnaire and cognitive outcomes, including postoperative delirium and cognitive status. Pain scores, opioid consumption, recovery room stay, postoperative complications, and patient satisfaction will also be recorded. The anesthesia technique will be determined by the attending anesthesiologist as part of routine clinical practice, and the researchers will not interfere with the choice of anesthesia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 65 years or older

ASA physical status I-III

Scheduled to undergo elective or emergency hip fracture surgery under general anesthesia

Provision of informed consent by the patient and/or legal representative

Disqualifiers

Refusal to participate in the study

ASA physical status IV-V

Severe pre-existing neurological or psychiatric disorders, including advanced dementia or severe cognitive impairment preventing communication

Known hypersensitivity or allergy to propofol or sevoflurane

Trial population

Patients aged 65 years or older undergoing hip fracture surgery under general anesthesia at Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital. Participants will be observed according to the anesthesia technique used as part of routine clinical practice: propofol-based total intravenous anesthesia or sevoflurane-based inhalational anesthesia.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Propofol-based Total Intravenous Anesthesia

    Other intervention

    Propofol-based total intravenous anesthesia administered according to routine clinical practice during hip fracture surgery.

  • Sevoflurane-based Inhalational Anesthesia

    Other intervention

    Sevoflurane-based inhalational anesthesia administered according to routine clinical practice during hip fracture surgery.

Treatment groups

110 Participants
are divided into 2 treatment groups
Group A: TIVA1 intervention
Group B: Sevoflurane1 intervention

Trial outcomes

Primary outcomes

1

Quality of Recovery-40 (QoR-40) Score on Postoperative Day 1

Postoperative quality of recovery will be assessed using the Quality of Recovery-40 (QoR-40) questionnaire. The QoR-40 consists of 40 items evaluating five dimensions of recovery: physical comfort, emotional state, physical independence, psychological support, and pain. Higher total scores indicate better quality of recovery.

Time frame
Postoperative day 1

Secondary outcomes

1

Quality of Recovery-40 (QoR-40) Score on Postoperative Day 2

Quality of recovery will be reassessed using the QoR-40 questionnaire.

Time frame
Postoperative day 2
2

Incidence of Postoperative Delirium

Postoperative delirium will be assessed using the 3D-CAM assessment.

Time frame
Postoperative day 1
3

Postoperative Pain Intensity

Postoperative pain intensity will be evaluated using the Numerical Rating Scale (NRS).

Time frame
Postoperative days 1 and 2
4

Postoperative Opioid Consumption

Total postoperative opioid consumption will be recorded from routine clinical records.

Time frame
Up to postoperative day 2

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.